Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma

被引：15

作者：

Kumar, S. K. ^{[1
]}

Ma, E. ^{[2
]}

Engebretson, A. E. ^{[1
]}

Buadi, F. K. ^{[1
]}

Lacy, M. Q. ^{[1
]}

Dispenzieri, A. ^{[1
]}

Duh, M. S. ^{[3
]}

Lafeuille, M-H ^{[3
]}

Lefebvre, P. ^{[4
]}

Cheng, W. Y. ^{[3
]}

Dea, K. ^{[4
]}

Rembert, D. ^{[5
]}

Patt, D. ^{[5
]}

Niculescu, L. ^{[2
]}

Quick, M. ^{[2
]}

Rajkumar, S. V. ^{[1
]}

机构：

[1] Mayo Clin, Div Hematol, Rochester, MN USA

[2] Millennium Pharmaceut Inc, Cambridge, MA USA

[3] Anal Grp Inc, Boston, MA USA

[4] Ltee, Grp Anal, Montreal, PQ, Canada

[5] McKesson Specialty Hlth, The Woodlands, TX USA

来源：

LEUKEMIA | 2016年 / 30卷 / 04期

关键词：

PHASE-II; INDUCTION; THERAPIES; SURVIVAL; IMPACT;

D O I：

10.1038/leu.2015.225

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：995 / 998

页数：5

共 16 条

[1] Efficacy and safety of once-weekly bortezomib in multiple myeloma patients [J].

Bringhen, Sara ;

Larocca, Alessandra ;

Rossi, Davide ;

Cavalli, Maide ;

Genuardi, Mariella ;

Ria, Roberto ;

Gentili, Silvia ;

Patriarca, Francesca ;

Nozzoli, Chiara ;

Levi, Anna ;

Guglielmelli, Tommasina ;

Benevolo, Giulia ;

Callea, Vincenzo ;

Rizzo, Vincenzo ;

Cangialosi, Clotilde ;

Musto, Pellegrino ;

De Rosa, Luca ;

Liberati, Anna Marina ;

Grasso, Mariella ;

Falcone, Antonietta P. ;

Evangelista, Andrea ;

Cavo, Michele ;

Gaidano, Gianluca ;

Boccadoro, Mario ;

Palumbo, Antonio .

BLOOD, 2010, 116 (23) :4745-4753

[2] Renal Improvement in Myeloma with Bortezomib plus Plasma Exchange [J].

Burnette, Brian L. ;

Leung, Nelson ;

Rajkumar, S. Vincent .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24) :2365-2366

[3] Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study [J].

Cavo, Michele ;

Tacchetti, Paola ;

Patriarca, Francesca ;

Petrucci, Maria Teresa ;

Pantani, Lucia ;

Galli, Monica ;

Di Raimondo, Francesco ;

Crippa, Claudia ;

Zamagni, Elena ;

Palumbo, Antonio ;

Offidani, Massimo ;

Corradini, Paolo ;

Narni, Franco ;

Spadano, Antonio ;

Pescosta, Norbert ;

Deliliers, Giorgio Lambertenghi ;

Ledda, Antonio ;

Cellini, Claudia ;

Caravita, Tommaso ;

Tosi, Patrizia ;

Baccarani, Michele .

LANCET, 2010, 376 (9758) :2075-2085

[4] Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group [J].

Dimopoulos, Meletios A. ;

Terpos, Evangelos ;

Chanan-Khan, Asher ;

Leung, Nelson ;

Ludwig, Heinz ;

Jagannath, Sundar ;

Niesvizky, Ruben ;

Giralt, Sergio ;

Fermand, Jean-Paul ;

Blade, Joan ;

Comenzo, Raymond L. ;

Sezer, Orhan ;

Palumbo, Antonio ;

Harousseau, Jean-Luc ;

Richardson, Paul G. ;

Barlogie, Bart ;

Anderson, Kenneth C. ;

Sonneveld, Pieter ;

Tosi, Patrizia ;

Cavo, Michele ;

Rajkumar, S. Vincent ;

Durie, Brian G. M. ;

San Miguel, Jesus .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) :4976-4984

[5] European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma [J].

Engelhardt, Monika ;

Terpos, Evangelos ;

Kleber, Martina ;

Gay, Francesca ;

Waesch, Ralph ;

Morgan, Gareth ;

Cavo, Michele ;

van de Donk, Niels ;

Beilhack, Andreas ;

Bruno, Benedetto ;

Johnsen, Hans Erik ;

Hajek, Roman ;

Driessen, Christoph ;

Ludwig, Heinz ;

Beksac, Meral ;

Boccadoro, Mario ;

Straka, Christian ;

Brighen, Sara ;

Gramatzki, Martin ;

Larocca, Alessandra ;

Lokhorst, Henk ;

Magarotto, Valeria ;

Morabito, Fortunato ;

Dimopoulos, Meletios A. ;

Einsele, Hermann ;

Sonneveld, Pieter ;

Palumbo, Antonio .

HAEMATOLOGICA, 2014, 99 (02) :232-242

[6] Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents [J].

Gaultney, J. G. ;

Franken, M. G. ;

Tan, S. S. ;

Redekop, W. K. ;

Huijgens, P. C. ;

Sonneveld, P. ;

Uyl-de Groot, C. A. .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (01) :41-47

[7] Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients [J].

Kumar, S. K. ;

Dispenzieri, A. ;

Lacy, M. Q. ;

Gertz, M. A. ;

Buadi, F. K. ;

Pandey, S. ;

Kapoor, P. ;

Dingli, D. ;

Hayman, S. R. ;

Leung, N. ;

Lust, J. ;

McCurdy, A. ;

Russell, S. J. ;

Zeldenrust, S. R. ;

Kyle, R. A. ;

Rajkumar, S. V. .

LEUKEMIA, 2014, 28 (05) :1122-1128

[8] Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma [J].

Kumar, Shaji ;

Flinn, Ian ;

Richardson, Paul G. ;

Hari, Parameswaran ;

Callander, Natalie ;

Noga, Stephen J. ;

Stewart, A. Keith ;

Turturro, Francesco ;

Rifkin, Robert ;

Wolf, Jeffrey ;

Estevam, Jose ;

Mulligan, George ;

Shi, Hongliang ;

Webb, Iain J. ;

Rajkumar, S. Vincent .

BLOOD, 2012, 119 (19) :4375-4382

[9] Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics [J].

Kumar, Shaji ;

Fonseca, Rafael ;

Ketterling, Rhett P. ;

Dispenzieri, Angela ;

Lacy, Martha Q. ;

Gertz, Morie A. ;

Hayman, Suzanne R. ;

Buadi, Francis K. ;

Dingli, David ;

Knudson, Ryan A. ;

Greenberg, Alexandra ;

Russell, Stephen J. ;

Zeldenrust, Steven R. ;

Lust, John A. ;

Kyle, Robert A. ;

Bergsagel, Leif ;

Rajkumar, S. Vincent .

BLOOD, 2012, 119 (09) :2100-2105

[10] Improved survival in multiple myeloma and the impact of novel therapies [J].

Kumar, Shaji K. ;

Rajkumar, S. Vincent ;

Dispenzieri, Angela ;

Lacy, Martha Q. ;

Hayman, Suzanne R. ;

Buadi, Francis K. ;

Zeldenrust, Steven R. ;

Dingli, David ;

Russell, Stephen J. ;

Lust, John A. ;

Greipp, Philip R. ;

Kyle, Robert A. ;

Gertz, Morie A. .

BLOOD, 2008, 111 (05) :2516-2520

← 1 2 →